Page last updated: 2024-11-05

4-nitropyridine 1-oxide

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Cross-References

ID SourceID
PubMed CID14300
CHEMBL ID3187617
SCHEMBL ID768956
MeSH IDM0061522

Synonyms (51)

Synonym
nsc-130895
AC-5155
4-nitropyridine n-oxide
wln: t6nj ao dnw
1124-33-0
4-nitropyridine-n-oxide
p-nitropyridine n-oxide
nsc5079
4-nitropyridine oxide
4-nitropyridine 1-oxide
nsc-5079
4-(hydroxy(oxido)amino)-1lambda~5~-pyridin-1-ol
nsc130895
4-nitro-1-oxido-pyridin-1-ium
AB-323/25048155
pyridine-1-oxide, 4-nitro-
pyridine, 4-nitro-, 1-oxide
AKOS000281983
4-nitro-1-oxidopyridin-1-ium
N0410
STK801375
NCGC00248141-01
ulb29z652d ,
4-nitropyridine-1-oxide
tox21_300690
NCGC00254598-01
cas-1124-33-0
dtxcid7021524
dtxsid9041524 ,
BBL009979
4-nitropyridin-1-ium-1-olate
FT-0619296
AB00617
pyridine, 4-nitro-, 1-oxide [hsdb]
4-nitro-pyridine n-oxide
4-nitro-pyridine-n-oxide
RXKNNAKAVAHBNK-UHFFFAOYSA-N
4-nitropyridin-1-oxide
SCHEMBL768956
STR00842
Q-101515
CHEMBL3187617
mfcd00006206
F1905-6987
BCP16314
Q230018
2-butenoic acid, 2-cyano-3-(2-methylphenyl)-, ethyl ester
EN300-16691
CS-0128813
4-nitropyridine-d4n-oxide
Z56755636
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Protein Targets (21)

Potency Measurements

ProteinTaxonomyMeasurementAverage (µ)Min (ref.)Avg (ref.)Max (ref.)Bioassay(s)
RAR-related orphan receptor gammaMus musculus (house mouse)Potency11.42940.006038.004119,952.5996AID1159521; AID1159523
SMAD family member 2Homo sapiens (human)Potency61.64480.173734.304761.8120AID1346924
SMAD family member 3Homo sapiens (human)Potency61.64480.173734.304761.8120AID1346924
GLI family zinc finger 3Homo sapiens (human)Potency29.76540.000714.592883.7951AID1259368; AID1259369; AID1259392
AR proteinHomo sapiens (human)Potency50.84900.000221.22318,912.5098AID1259243; AID1259247; AID743054; AID743063
estrogen receptor 2 (ER beta)Homo sapiens (human)Potency55.93330.000657.913322,387.1992AID1259377; AID1259378
nuclear receptor subfamily 1, group I, member 3Homo sapiens (human)Potency43.84150.001022.650876.6163AID1224838; AID1224839; AID1224893
estrogen-related nuclear receptor alphaHomo sapiens (human)Potency31.03740.001530.607315,848.9004AID1224848; AID1224849; AID1259403
pregnane X nuclear receptorHomo sapiens (human)Potency76.95880.005428.02631,258.9301AID1346982
estrogen nuclear receptor alphaHomo sapiens (human)Potency60.66860.000229.305416,493.5996AID1259244; AID1259248; AID1259383; AID743069; AID743078; AID743079; AID743080; AID743091
peroxisome proliferator-activated receptor deltaHomo sapiens (human)Potency27.53570.001024.504861.6448AID743215
peroxisome proliferator activated receptor gammaHomo sapiens (human)Potency48.96620.001019.414170.9645AID743191
vitamin D (1,25- dihydroxyvitamin D3) receptorHomo sapiens (human)Potency54.94100.023723.228263.5986AID743223
cytochrome P450, family 19, subfamily A, polypeptide 1, isoform CRA_aHomo sapiens (human)Potency68.58960.001723.839378.1014AID743083
thyroid stimulating hormone receptorHomo sapiens (human)Potency76.95880.001628.015177.1139AID1259385
v-jun sarcoma virus 17 oncogene homolog (avian)Homo sapiens (human)Potency46.30370.057821.109761.2679AID1159526; AID1159528
Histone H2A.xCricetulus griseus (Chinese hamster)Potency71.30090.039147.5451146.8240AID1224845
thyroid hormone receptor beta isoform 2Rattus norvegicus (Norway rat)Potency68.58960.000323.4451159.6830AID743065; AID743067
nuclear factor erythroid 2-related factor 2 isoform 1Homo sapiens (human)Potency30.63790.000627.21521,122.0200AID743202
Voltage-dependent calcium channel gamma-2 subunitMus musculus (house mouse)Potency54.48270.001557.789015,848.9004AID1259244
Glutamate receptor 2Rattus norvegicus (Norway rat)Potency54.48270.001551.739315,848.9004AID1259244
[prepared from compound, protein, and bioassay information from National Library of Medicine (NLM), extracted Dec-2023]

Ceullar Components (1)

Processvia Protein(s)Taxonomy
plasma membraneGlutamate receptor 2Rattus norvegicus (Norway rat)
[Information is prepared from geneontology information from the June-17-2024 release]

Bioassays (8)

Assay IDTitleYearJournalArticle
AID1871190Inhibition of biofilm formation in Pseudomonas aeruginosa at 100 uM measured after 48 hrs relative to control2021RSC medicinal chemistry, Dec-15, Volume: 12, Issue:12
2-Difluoromethylpyridine as a bioisosteric replacement of pyridine-
AID1754674Inhibition of quorum sensing system in Chromobacterium violaceum ATCC 31532 assessed as reduction in violacein production at 100 uM2021Bioorganic & medicinal chemistry letters, 08-15, Volume: 46Discovery of novel β-turn mimetic-based peptides as novel quorum sensing inhibitors of gram-negative bacteria.
AID1871192Activation of protease (unknown origin)2021RSC medicinal chemistry, Dec-15, Volume: 12, Issue:12
2-Difluoromethylpyridine as a bioisosteric replacement of pyridine-
AID1871189Inhibition of quorum sensing system in Pseudomonas aeruginosa transfected with lasB-gfp2021RSC medicinal chemistry, Dec-15, Volume: 12, Issue:12
2-Difluoromethylpyridine as a bioisosteric replacement of pyridine-
AID1754676Antibiofilm activity against Pseudomonas aeruginosa PA14 assessed as inhibition of biofilm formation at 15 to 50 uM measured after 48 hrs2021Bioorganic & medicinal chemistry letters, 08-15, Volume: 46Discovery of novel β-turn mimetic-based peptides as novel quorum sensing inhibitors of gram-negative bacteria.
AID1436366Inhibition of quorum sensing system in Agrobacterium tumefaciens harboring traG-LacZ reporter fusion measured after 4 hrs by beta-galactosidase reporter gene assay2017European journal of medicinal chemistry, Jan-27, Volume: 126Fusaric acid and analogues as Gram-negative bacterial quorum sensing inhibitors.
AID1754673Inhibition of quorum sensing system lasB in Pseudomonas aeruginosa transfected with lasB-gfp assessed as reduction of GFP production2021Bioorganic & medicinal chemistry letters, 08-15, Volume: 46Discovery of novel β-turn mimetic-based peptides as novel quorum sensing inhibitors of gram-negative bacteria.
AID1871191Inhibition of quorum sensing system in Chromobacterium violaceum ATCC 31352 assessed as reduction in violacein production at 100 uM relative to control2021RSC medicinal chemistry, Dec-15, Volume: 12, Issue:12
2-Difluoromethylpyridine as a bioisosteric replacement of pyridine-
[information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (14)

TimeframeStudies, This Drug (%)All Drugs %
pre-19902 (14.29)18.7374
1990's1 (7.14)18.2507
2000's3 (21.43)29.6817
2010's6 (42.86)24.3611
2020's2 (14.29)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 12.28

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be weak demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index12.28 (24.57)
Research Supply Index2.71 (2.92)
Research Growth Index4.99 (4.65)
Search Engine Demand Index0.00 (26.88)
Search Engine Supply Index0.00 (0.95)

This Compound (12.28)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews0 (0.00%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other14 (100.00%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]